Company · CIK 1701541

# Black Diamond Therapeutics, Inc.

| CIK | [1701541](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001701541) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Business address | MA |
| Listed | BDTX (Nasdaq) |
| First annual or quarterly report | 2020-03-24 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-291518 | Shelf Effective | 2025-11-13 | 2025-12-03 | 2 |
| 333-268341 | Shelf Effective | 2022-11-14 | 2023-06-30 | 4 |
| 333-252627 | Shelf Effective | 2021-02-01 | 2021-02-01 | 1 |
| 333-235789 | IPO Final prospectus | 2020-01-03 | 2020-01-30 | 4 |

## Filings

 12

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-12-03 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1701541/999999999525003511/9999999995-25-003511-index.htm) Declared effective | 333-291518 | 9999999995-25-003511 |
| 2025-11-13 | [S-3](https://www.sec.gov/Archives/edgar/data/1701541/000110465925111490/0001104659-25-111490-index.htm) Shelf registered | 333-291518 | 0001104659-25-111490 |
| 2023-06-30 | [424B5](https://www.sec.gov/Archives/edgar/data/1701541/000110465923077054/0001104659-23-077054-index.htm) Shelf takedown | 333-268341 | 0001104659-23-077054 |
| 2023-06-29 | [424B5](https://www.sec.gov/Archives/edgar/data/1701541/000110465923075983/0001104659-23-075983-index.htm) Shelf takedown | 333-268341 | 0001104659-23-075983 |
| 2022-11-22 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1701541/999999999522003381/9999999995-22-003381-index.htm) Declared effective | 333-268341 | 9999999995-22-003381 |
| 2022-11-14 | [S-3](https://www.sec.gov/Archives/edgar/data/1701541/000119312522284590/0001193125-22-284590-index.htm) Shelf registered | 333-268341 | 0001193125-22-284590 |
| 2021-02-01 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1701541/000119312521024779/0001193125-21-024779-index.htm) Shelf registered | 333-252627 | 0001193125-21-024779 |
| 2020-01-30 | [424B4](https://www.sec.gov/Archives/edgar/data/1701541/000119312520019694/0001193125-20-019694-index.htm) Final prospectus | 333-235789 | 0001193125-20-019694 |
| 2020-01-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1701541/999999999520000183/9999999995-20-000183-index.htm) Declared effective | 333-235789 | 9999999995-20-000183 |
| 2020-01-21 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1701541/000119312520010637/0001193125-20-010637-index.htm) Amendment | 333-235789 | 0001193125-20-010637 |
| 2020-01-03 | [S-1](https://www.sec.gov/Archives/edgar/data/1701541/000119312520001336/0001193125-20-001336-index.htm) Registration filed | 333-235789 | 0001193125-20-001336 |
| 2019-08-23 | [DRS](https://www.sec.gov/Archives/edgar/data/1701541/000095012319008650/0000950123-19-008650-index.htm) Draft made public | 377-02808 | 0000950123-19-008650 |

[All filings of this company](https://equitycapital.markets/filings?cik=1701541) · [CSV](https://equitycapital.markets/filings.csv?cik=1701541)

---
Source page: https://equitycapital.markets/company/1701541 · Data: U.S. SEC EDGAR · CC BY 4.0